Cargando…
Construction and verification of the targeted uPA-shRNA lentiviral vector and evaluation of the transfection and silencing rate
Urokinase-type plasminogen activator (uPA) receptors, which are released by the synovial tissue, are responsible for the activation of cartilage-breakdown proteases and play critical roles in cartilage degradation during the progression of osteoarthritis (OA). RNA interference (RNAi) technology has...
Autores principales: | WANG, WEI-SHAN, GUO, FENG-JING, LI, CHANG-JUN, ZHANG, ZHEN-DONG, SHI, CHEN-HUI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079424/ https://www.ncbi.nlm.nih.gov/pubmed/25009597 http://dx.doi.org/10.3892/etm.2014.1741 |
Ejemplares similares
-
Construction of shRNA lentiviral vector
por: Song, Hong, et al.
Publicado: (2010) -
Construction of a Single Lentiviral Vector Containing Tetracycline-Inducible Alb-uPA for Transduction of uPA Expression in Murine Hepatocytes
por: Bai, Jiasi, et al.
Publicado: (2013) -
TEM8 functions as a receptor for uPA and mediates uPA-stimulated EGFR phosphorylation
por: Zhang, Lian-Cheng, et al.
Publicado: (2018) -
A Comparison of Target Gene Silencing using Synthetically Modified siRNA and shRNA That Express Recombinant Lentiviral Vectors
por: Spirin, P.V., et al.
Publicado: (2009) -
Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition
por: Brake, Olivier ter, et al.
Publicado: (2008)